| Networks of tau distribution in Alzheimer’s disease MC Hoenig, GN Bischof, J Seemiller, J Hammes, J Kukolja, ÖA Onur, ... Brain 141 (2), 568-581, 2018 | 163 | 2018 |
| Tau pathology and cognitive reserve in Alzheimer's disease MC Hoenig, GN Bischof, J Hammes, J Faber, K Fliessbach, ... Neurobiology of aging 57, 1-7, 2017 | 76 | 2017 |
| Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control J Hammes, H Theis, K Giehl, MC Hoenig, A Greuel, M Tittgemeyer, ... Brain 142 (3), 733-743, 2019 | 73 | 2019 |
| Connectomics and molecular imaging in neurodegeneration GN Bischof, M Ewers, N Franzmeier, MJ Grothe, M Hoenig, E Kocagoncu, ... European journal of nuclear medicine and molecular imaging 46, 2819-2830, 2019 | 28 | 2019 |
| One-stop shop: 18F-flortaucipir PET differentiates amyloid-positive and-negative forms of neurodegenerative diseases J Hammes, GN Bischof, KP Bohn, Ö Onur, A Schneider, K Fliessbach, ... Journal of nuclear medicine 62 (2), 240-246, 2021 | 26 | 2021 |
| Level of education mitigates the impact of tau pathology on neuronal function MC Hoenig, GN Bischof, ÖA Onur, J Kukolja, F Jessen, K Fliessbach, ... European journal of nuclear medicine and molecular imaging 46, 1787-1795, 2019 | 24 | 2019 |
| Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease J Pfeil, MC Hoenig, E Doering, T van Eimeren, A Drzezga, GN Bischof, ... Neurobiology of aging 106, 119-129, 2021 | 20 | 2021 |
| Gray Matter Volume Loss in Proposed Brain‐First and Body‐First Parkinson's Disease Subtypes M Banwinkler, V Dzialas, Parkinson's Progression Markers Initiative, ... Movement disorders 37 (10), 2066-2074, 2022 | 19 | 2022 |
| Clinical effect of early vs late amyloid positron emission tomography in memory clinic patients: the AMYPAD-DPMS randomized clinical trial D Altomare, F Barkhof, C Caprioglio, LE Collij, P Scheltens, IL Alves, ... JAMA neurology 80 (6), 548-557, 2023 | 18 | 2023 |
| Analysis of psychological symptoms following disclosure of amyloid–positron emission tomography imaging results to adults with subjective cognitive decline C Caprioglio, F Ribaldi, LNC Visser, C Minguillon, LE Collij, ... JAMA network open 6 (1), e2250921-e2250921, 2023 | 18 | 2023 |
| Indication of retrograde tau spreading along Braak stages and functional connectivity pathways J Seemiller, GN Bischof, MC Hoenig, M Tahmasian, T van Eimeren, ... European journal of nuclear medicine and molecular imaging 48, 2272-2282, 2021 | 17 | 2021 |
| Assessment of tau tangles and amyloid-β plaques among super agers using PET imaging MC Hoenig, N Willscheid, GN Bischof, T van Eimeren, A Drzezga, ... JAMA Network Open 3 (12), e2028337-e2028337, 2020 | 15 | 2020 |
| The concept of motor reserve in Parkinson's disease: new wine in old bottles? MC Hoenig, T van Eimeren, V Dzialas, A Drzezga Movement disorders 38 (FZJ-2023-00164), 16-20, 2023 | 13 | 2023 |
| MRI or 18F-FDG PET for brain age gap estimation: Links to cognition, pathology, and Alzheimer disease progression E Doering, G Antonopoulos, M Hoenig, T van Eimeren, M Daamen, ... Journal of nuclear medicine 65 (1), 147-155, 2024 | 8 | 2024 |
| Clear‐headed into old age: Resilience and resistance against brain aging—A PET imaging perspective MC Hoenig, A Drzezga Journal of neurochemistry 164 (3), 325-345, 2023 | 6 | 2023 |
| Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease M Hönig, D Altomare, C Caprioglio, L Collij, F Barkhof, B Van Berckel, ... Neurology 102 (6), e208053, 2024 | 5 | 2024 |
| Impulsive-compulsive behaviour in early Parkinson’s disease is determined by apathy and dopamine receptor D3 polymorphism H Theis, S Prange, GN Bischof, MC Hoenig, M Tittgemeyer, ... npj Parkinson's Disease 9 (1), 154, 2023 | 4 | 2023 |
| Educational level and its association with dopamine transporter loss in patients with Parkinson's disease MC Hoenig, V Dzialas, M Banwinkler, A Asendorf, A Drzezga, ... Parkinsonism & Related Disorders 115, 105844, 2023 | 3 | 2023 |
| Resistance to Tau and Amyloid Pathology Facilitates Super-Aging M Hoenig, G Bischof, N Willscheid, T van Eimeren, A Drzezga, ... Journal of Nuclear Medicine 61 (supplement 1), 20-20, 2020 | 3 | 2020 |
| Putaminal dopamine modulates movement motivation in Parkinson’s disease M Banwinkler, V Dzialas, L Rigoux, AL Asendorf, H Theis, K Giehl, ... Brain 147 (10), 3352-3357, 2024 | 2 | 2024 |
